Abstract
The retention rate of the spin label 3-isothiocyanto methyl-2,2,5,5-tetramethyl-1-pyrrolidinyl oxyl spin label (proxyl) attached to the porcine N-acetyl-NPY peptide and the porcine N-acetyl-D-Trp32-NPY peptide at Lys4 was investigated using SK-N-MC neuroblastoma cell membranes containing the Y1 receptor. The release rate of the spin labeled peptides was monitored by electron spin resonance and the KD was determined by a direct radiolabeled NPY displacement binding assay. The analyses show that for the porcine [Ac-Tyr1Nε4-proxyl]-NPY, the KD was 8 × 10−10 M and koff was 2.7 × 10−4 sec−1 yielding a value for kon of 3.3 × 105 sec−1 M−1. The [Ac-Tyr1, Nε4-proxyl,-D-Trp32]-NPY antagonist ligand had a value of KD equal to 1.35 × 10−7 M and koff was 1.7 × 10−4 sec−1 leading to a value for kon of 1.2 × 103 sec−1 M−1. The difference in the kon rates of two orders of magnitude is interpreted as demonstrating the N-acetyl-Nε4 proxyl-D-Trp32-NPY ligand binding transition state to be of higher energy then for the unmodified NPY amino acid sequence.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Stanley, B. G., and Leibowitz, S. F. 1985. Neuropeptide Y injected in the paraventricular hypothalamus: a powerful stimulant of feeding behavior. Proc. Natl. Acad. Sci. (USA) 82:3940–3943.
Albers, H. E., and Ferris, C. F. 1984. Neuropeptide Y: role in light-dark cycle entrainment of hamster circadian rhythms. Neurosci. Lett. 50:163–168.
Drumheller, A., Rivest, R., Michaud, J. N., St. Pierre, S., and Jolicoeur, F. B. 1988. The profile of neurobehaviorial effects produced by neuropeptide Y. Soc. Neurosci. Abstr. 14:287.
Heilig, M., and Widerlöv, E. 1990, Neuropeptide Y: An overview of central nervous distribution, functional aspects and possible involvement in neuropsychiatreic illnesses. Acta. Psychiat. Scand. 82:95–114.
Aakerlund, L., Gether, U., Fuhlendorff, J., Schwartz, T. W., and Thastrup, O. 1990. Y1 receptors for neuropeptide Y are coupled to mobilization of intracellular calcium and inhibition of adenylate cyclase. FEBS Letters 260:73–78.
Tatemoto, K., Carlquist, M., and Mutt, V. 1982a. Neuropeptide Y: a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature (London) 296:659–660.
Tatemoto, K. 1982b. Neuropeptide Y: Complete amino acid sequence of the brain peptide. Proc. Nat'l. Acad. Sci. (USA) 79:5485–5489.
Tatemoto, K. 1982c. Isolation and characterization of peptide YY(PYY), a candidate gut hormone that inhibits pancreatic exocrine secretion. Proc. Nat'l. Acad. Sci. (USA) 79:2514–2518.
Kimmel, J., Hayden, J., and Pollock, G. 1975. Isolation and characterization of a new pancreatic polypeptide hormone. J. Biol. Chem. 250:9369–9376.
Beck-Sickinger, A. G., and Jung, G. 1995. Structure-Activity relationships to neuropeptide Y analogues with respect to Y1 and Y2 receptors. Biopolymers (Peptide Science) 37:123–142.
Krstenansky, J. L., and Buck, S. H. 1987. The synthesis, physical characterization and receptor binding affinity of neuropeptide Y (NPY). Neuropeptides 10:77–85.
Saudek, V., and Pelton, J. T. 1990. Sequence specific 1H NMR assignment and secondary structure of neuropeptide Y in aqueous solution. Biochemistry 29:4509–4515.
Arvidsson, K., Land, T., Langel, U., Bartfai, T., and Ehrenberg, A. 1993. Solution structure by 2D 1H NMR of a chimeric peptide recognized by galanin and neuropeptide Y Receptors. Biochemistry 32:7787–7798.
Blundell, T. L., Pitts, J. E., Tickle, I. J., Wood, S. P. and Wu, C.-W. 1981. X-ray analysis (1.4Å resolution) of avian pancreatic polypeptide: small globular protein hormone. Proc. Natl. Acad. Sci. U.S.A. 78:4175–4179.
Cowley, D. J., Hoflack, J. M., Pelton, J. T., Saudek, V. (1992). Structure of neuropeptide Y dimer in solution. Eur. J. Biochem. 205:206, 39–48.
Michel, M. C. 1991. Receptors for neuropeptide Y: multiple subtypes and multiple second messengers. Trends Pharmacol. Sci. 12:389–394.
Herzog, H., Hort, Y. J., Ball, H. J., Hayes, G., Shine, J., and Selbie, L. A. 1992. Cloned human neuropeptide Y receptor couples to two different second messenger systems. Proc. Natl. Acad. Sci. U.S.A. 89:5794–5798.
Larhammar, D., Blomqvist, A. G., Yee, F., Jazin, E., Yoo, H., and Wahlstestedt, C. 1992. Cloning and functional expression of a human neuropeptide Y/peptide YY receptor of the Y1 type. J. Biol. Chem. 267:10935–10938.
Krause, J., Eva, C., Seeburg, P., and Sprengel, R. 1992. Neuropeptide Y1 subtype pharmacology of a recombinantly expressed neuropeptide receptor. Mol. Pharmacol. 41:817–821.
Balasubramaniam, A., Sheriff, S., Johnson, M. E., Prabhakaran, M., Huang, Y., Fischer, J. E., and Chance, W. T. 1994. [D-TRP32] neuropeptide Y: A Competitive antagonist of NPY in rat hypothalamus. J. Med. Chem. 37:811–815.
Gordon, E. A., Kohout, T. A., and Fishman, P. H. 1990. Characterization of functional neuropeptide Y receptors in a human neuroblastoma cell line. J. Neurochem. 55:506–513.
Grundemar, L., Sheikh, S. P., and Wahlestedt, C. 1993. Characterization of receptor types for neuropeptide Y and related peptides. Pages 197–239, in Colmers, W. F. and Wahlestedt, C., (eds.) The Biology of Neuropeptide Y and Related Peptides Humana Press, Totowa, NJ.
Lobaugh, L. A., and Blackshear, P. J. 1990. Neuropeptide Y binding and inhibition of cAMP accumulation in human neuroepithelioma cells. Am. J. Physiol. 258:C913–922.
Cheng, Y.-C., and Prussoff, W. H. 1973. Relationship between the inhibition constant (K 1) and the concentration of inhibitor which causes 50 per cent inhibition (I 50) of an enzymatic reaction. Biochemical Pharmacology 22:3099–3108.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zand, R., Marcelo, C.L., MacKenzie, R. et al. Substitution of D-Trp32 in NPY Destabilizes the Binding Transition State to the Y1 Receptor Site in SK-N-MC Cell Membranes. Neurochem Res 22, 437–443 (1997). https://doi.org/10.1023/A:1027307710425
Issue Date:
DOI: https://doi.org/10.1023/A:1027307710425